Staphylococcal Skin Infections
Information
- Disease name
- Staphylococcal Skin Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02814916 | Completed | Phase 3 | Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA | March 31, 2017 | December 31, 2023 |
| NCT00228982 | Completed | Phase 3 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | October 2004 | December 2005 |
| NCT01419184 | Completed | Phase 4 | Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA | September 9, 2011 | October 5, 2012 |
| NCT02582203 | Completed | Phase 4 | Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA | February 2012 | May 2016 |
| NCT00210899 | Completed | Phase 3 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | September 2005 | October 2006 |
| NCT00475930 | Completed | N/A | Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates | May 2007 | November 2007 |
| NCT00513799 | Completed | N/A | The Natural History of Community-Associated MRSA Infections and Decolonization Strategies | March 2007 | December 2010 |
| NCT00514527 | Completed | Phase 2 | A Study for Patients With Complicated Skin and Skin Structure Infections | August 2007 | May 2008 |
| NCT00646958 | Completed | Phase 2 | Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections | December 2007 | April 2008 |
| NCT00719810 | Completed | Phase 2 | Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections | June 2008 | October 2008 |
| NCT00731783 | Completed | N/A | Staphylococcus Aureus Decolonization Study | July 2008 | December 2010 |
| NCT00737269 | Completed | A Complicated Skin and Soft-tissue Infection Patient Registry | June 2008 | January 2010 | |
| NCT01018641 | Completed | Phase 1 | An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults | January 2010 | July 2011 |
| NCT01026558 | Completed | Phase 1 | A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | August 2007 | November 2007 |
| NCT01026636 | Completed | Phase 1 | A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age | August 2007 | April 2010 |
| NCT01026740 | Completed | Phase 1 | Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers | June 2007 | September 2007 |
| NCT01030731 | Completed | Phase 1 | Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease | May 2007 | August 2007 |
| NCT01105767 | Completed | N/A | Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees | May 2010 | January 2012 |
| NCT01198262 | Completed | Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections | April 2008 | August 2010 | |
| NCT00463801 | Terminated | Phase 4 | Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections | January 2007 | |
| NCT00492271 | Terminated | Phase 1 | First Time in Man Trial for Friulimicin B | June 2007 | September 2007 |
| NCT02566928 | Unknown status | Phase 4 | Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence | October 2015 | December 31, 2018 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013207